相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
Laura W. Dillon et al.
HAEMATOLOGICA (2019)
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML
Yi Zhou et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Gerrit J. Schuurhuis et al.
BLOOD (2018)
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations
Sylvie D. Freeman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
Kiyomi Morita et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
Maja Rothenberg-Thurley et al.
LEUKEMIA (2018)
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
M. Jongen-Lavrencic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol et al.
BLOOD (2018)
Evaluating measurable residual disease in acute myeloid leukemia
Farhad Ravandi et al.
BLOOD ADVANCES (2018)
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia
Lukas Gaksch et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
Erik B. R. Malmberg et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Measurable residual disease testing in acute myeloid leukaemia
C. S. Hourigan et al.
LEUKEMIA (2017)
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley et al.
HAEMATOLOGICA (2017)
Initial Diagnostic Workup of Acute Leukemia Guideline From the College of American Pathologists and the American Society of Hematology
Daniel A. Arber et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia
Mary-Elizabeth Percival et al.
BLOOD REVIEWS (2017)
When the Minimal Becomes Measurable
Christopher S. Hourigan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
Daisuke Araki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Assessment of Minimal Residual Disease in Standard-Risk AML
A. Ivey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A multigene array for measurable residual disease detection in AML patients undergoing SCT
M. Goswami et al.
BONE MARROW TRANSPLANTATION (2015)
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
Jeffery M. Klco et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the acute leukemia french association
Houria Debarri et al.
ONCOTARGET (2015)
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Nestor R. Ramos et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia
Wei-Gang Tong et al.
HAEMATOLOGICA (2015)
Value of routine 'day 14' marrow exam in newly diagnosed AML
T. Yezefski et al.
LEUKEMIA (2015)
Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia
V. Vainstein et al.
LEUKEMIA (2014)
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
M. Goswami et al.
LEUKEMIA (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
Monique Terwijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
Tod A. Morris et al.
LEUKEMIA RESEARCH (2013)
Minimal residual disease in acute myeloid leukaemia
Christopher S. Hourigan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
Daniela Cilloni et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia
Kebede Hussein et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia
Masamitsu Yanada et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study
G Gianfaldoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Prognostic index for adult patients with acute myeloid leukemia in first relapse
DA Breems et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
